| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ezell Ryan Gillis | CEO, Director | 5775 N. SAM HOUSTON PARKWAY W., STE 400, HOUSTON | /s/ J. Bond Clement as attorney-in-fact | 03 Nov 2025 | 0001805598 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FTK | Common Shares | Tax liability | $147,562 | -7,870 | -5% | $18.75 | 149,511 | 30 Oct 2025 | Direct | F1 |
| transaction | FTK | Common Shares | Options Exercise | +30,000 | +20% | 179,511 | 30 Oct 2025 | Direct | F2 | ||
| transaction | FTK | Common Shares | Tax liability | $221,344 | -11,805 | -6.6% | $18.75 | 167,706 | 30 Oct 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FTK | Performance Based Restricted Stock Unit | Options Exercise | -30,000 | -100% | 0 | 30 Oct 2025 | Common Stock | 30,000 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Includes 526 shares Dr. Ezell acquired under Flotek Industries, Inc.'s 2012 Employee Stock Purchase Plan for the 3-month period commencing July 1, 2025. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | Each Performance Based Restricted Stock Unit represents a contingent right to receive one share of Flotek Industries, Inc. common stock subject to achieving a certain threshold on or before December 31, 2025. |